Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IONIC: IMU-838 and Oseltamivir in COVID-19
NCT04516915Phase 2Completed
- Sponsor
- University Hospitals Coventry and Warwickshire NHS Trust
- Start
- Jun 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vidofludimus calcium in coronavirus disease 2019 (COVID-19), sponsored by University Hospitals Coventry and Warwickshire NHS Trust. Started Jun 2020; status: completed.
02
Drugs
vidofludimus calcium
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04516915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04516915.